|
Volumn 26, Issue 3, 1999, Pages 276-289
|
Mycosis fungoides and the Sezary syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARMUSTINE;
CD4 ANTIGEN;
CD7 ANTIGEN;
CHLORMETHINE DERIVATIVE;
CYCLOPHOSPHAMIDE;
DENILEUKIN DIFTITOX;
DOXORUBICIN;
ETOPOSIDE;
ETRETIN;
ETRETINATE;
FLUDARABINE;
ISOTRETINOIN;
METHOTREXATE;
PENTOSTATIN;
PREDNISONE;
PSORALEN;
RETINOID;
T LYMPHOCYTE RECEPTOR;
UNCLASSIFIED DRUG;
VINBLASTINE;
VINCRISTINE;
ARTHRALGIA;
CANCER PALLIATIVE THERAPY;
CANCER STAGING;
CLINICAL FEATURE;
CLINICAL TRIAL;
ELECTRON BEAM;
ERYTHRODERMA;
GENE REARRANGEMENT;
HEADACHE;
HISTOPATHOLOGY;
HUMAN;
HYPERLIPIDEMIA;
LIVER TOXICITY;
MYALGIA;
MYCOSIS FUNGOIDES;
ORAL DRUG ADMINISTRATION;
PHOTOSENSITIVITY;
PHOTOTHERAPY;
PRIORITY JOURNAL;
PUVA;
REVIEW;
SEZARY SYNDROME;
TOPICAL DRUG ADMINISTRATION;
XEROSIS;
PATHOLOGY;
PROGNOSIS;
SKIN TUMOR;
HUMANS;
MYCOSIS FUNGOIDES;
NEOPLASM STAGING;
PROGNOSIS;
SEZARY SYNDROME;
SKIN NEOPLASMS;
|
EID: 0032588233
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (181)
|
References (86)
|